Renal and Metabolic Toxicities Following Initiation of HIV-1 Treatment Regimen in a Diverse, Multinational Setting: A Focused Safety Analysis of ACTG PEARLS (A5175)

Conclusions: TDF is associated with lower serious metabolic toxicities but not higher risk of RAs, serious renal events, or worsening CrCl over time compared to ZDV in this randomized multinational study. Content Type Journal ArticleCategory Original ArticlePages 246-260DOI 10.1310/hct1506-246Authors F. Touzard Romo, The Miriam Hospital, Providence, Rhode Island, USAL. M. Smeaton, Harvard School of Public Health, Boston, Massachusetts, USAT. B. Campbell, University of Colorado Denver, Aurora, Colorado, USAC. Riviere, Institut Nacional de Laboratoire et Recherches, Port-au-Prince, HaitiR. Mngqibisa, University of KwaZulu-Natal, Durban, South AfricaM. Nyirenda, College of Medicine – Johns Hopkins Research Project, Blantyre, MalawiK. Supparatpinyo, Chiang Mai University, Chiang Mai, ThailandN. Kumarasamy, YRG Centre for AIDS Research and Education, Chennai, IndiaJ. G. Hakim, University of Zimbabwe College of Health Sciences, Harare, ZimbabweT. P. Flanigan, The Miriam Hospital, Providence, Rhode Island, USA Journal HIV Clinical TrialsPrint ISSN 1528-4336 Journal Volume Volume 15 Journal Issue Volume 15, Number 6 / Nov-Dec 2014
Source: HIV Clinical Trials - Category: Infectious Diseases Tags: HIV Clinical Trials Source Type: research